Qiagen buys German Rosys for $16 million:
This article was originally published in Clinica
Executive Summary
Qiagen has bought the German company, Rosys, which makes robotic handling systems and liquid-handling instrumentation, for approximately $16 million in a stock-for-stock transaction. Rosys was an OEM supplier for five years to Qiagen's BioRobot lines. Qiagen is based in Venlo, Netherlands.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.